These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8276076

  • 1. Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo.
    Wu RM, Chiueh CC, Pert A, Murphy DL.
    Eur J Pharmacol; 1993 Oct 26; 243(3):241-7. PubMed ID: 8276076
    [Abstract] [Full Text] [Related]

  • 2. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
    Wu RM, Mohanakumar KP, Murphy DL, Chiueh CC.
    Ann N Y Acad Sci; 1994 Nov 17; 738():214-21. PubMed ID: 7832430
    [Abstract] [Full Text] [Related]

  • 3. Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity.
    Wu RM, Murphy DL, Chiueh CC.
    J Neural Transm Gen Sect; 1995 Nov 17; 100(1):53-61. PubMed ID: 8748663
    [Abstract] [Full Text] [Related]

  • 4. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct 17; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
    Wu WR, Zhu ZT, Zhu XZ.
    Life Sci; 2000 Jun 08; 67(3):241-50. PubMed ID: 10983868
    [Abstract] [Full Text] [Related]

  • 6. Suppression of hydroxyl radical formation and protection of nigral neurons by l-deprenyl (selegiline).
    Wu RM, Murphy DL, Chiueh CC.
    Ann N Y Acad Sci; 1996 Jun 15; 786():379-90. PubMed ID: 8687036
    [Abstract] [Full Text] [Related]

  • 7. Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.
    Wu RM, Chen RC, Chiueh CC.
    Ann N Y Acad Sci; 2000 Jun 15; 899():255-61. PubMed ID: 10863544
    [Abstract] [Full Text] [Related]

  • 8. Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures.
    Schmidt DE, Ebert MH, Lynn JC, Whetsell WO.
    J Neural Transm (Vienna); 1997 Jun 15; 104(8-9):875-85. PubMed ID: 9451719
    [Abstract] [Full Text] [Related]

  • 9. Local striatal infusion of MPP+ does not result in increased hydroxylation after systemic administration of 4-hydroxybenzoate.
    Ste-Marie L, Vachon L, Bémeur C, Lambert J, Montgomery J.
    Free Radic Biol Med; 1999 Nov 15; 27(9-10):997-1007. PubMed ID: 10569632
    [Abstract] [Full Text] [Related]

  • 10. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F, Pardini C, Cavalletti M, Maggio R, Corsini GU.
    Brain Res; 1996 Nov 25; 741(1-2):68-74. PubMed ID: 9001706
    [Abstract] [Full Text] [Related]

  • 11. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS, Sindhu KM, Senthilkumar KS, Mohanakumar KP.
    Neurochem Int; 2006 Jul 25; 49(1):28-40. PubMed ID: 16490285
    [Abstract] [Full Text] [Related]

  • 12. Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatum.
    Rose S, Hindmarsh JG, Jenner P.
    J Neural Transm (Vienna); 1999 Jul 25; 106(5-6):477-86. PubMed ID: 10443551
    [Abstract] [Full Text] [Related]

  • 13. In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors: electrospray-MS analysis of intra-striatal microdialysates.
    Boismenu D, Mamer O, Ste-Marie L, Vachon L, Montgomery J.
    J Mass Spectrom; 1996 Oct 25; 31(10):1101-8. PubMed ID: 8916419
    [Abstract] [Full Text] [Related]

  • 14. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia.
    Chiueh CC, Wu RM, Mohanakumar KP, Sternberger LM, Krishna G, Obata T, Murphy DL.
    Ann N Y Acad Sci; 1994 Nov 17; 738():25-36. PubMed ID: 7832434
    [Abstract] [Full Text] [Related]

  • 15. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Nov 17; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 16. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Mytilineou C, Cohen G.
    J Neurochem; 1985 Dec 17; 45(6):1951-3. PubMed ID: 3932598
    [Abstract] [Full Text] [Related]

  • 17. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
    Rothblat DS, Schneider JS.
    Brain Res; 1998 Jan 01; 779(1-2):226-30. PubMed ID: 9473679
    [Abstract] [Full Text] [Related]

  • 18. Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation.
    Obata T, Yamanaka Y, Kinemuchi H, Oreland L.
    Brain Res; 2001 Jul 06; 906(1-2):170-5. PubMed ID: 11430875
    [Abstract] [Full Text] [Related]

  • 19. Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in dopaminergic neurotoxicity.
    Chiueh CC, Huang SJ, Murphy DL.
    J Neural Transm Suppl; 1994 Jul 06; 41():189-96. PubMed ID: 7931226
    [Abstract] [Full Text] [Related]

  • 20. Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats.
    Sairam K, Saravanan KS, Banerjee R, Mohanakumar KP.
    Brain Res; 2003 Mar 21; 966(2):245-52. PubMed ID: 12618347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.